These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27243142)

  • 1. Chronic Cervicitis: Presenting Features and Response to Therapy.
    Mattson SK; Polk JP; Nyirjesy P
    J Low Genit Tract Dis; 2016 Jul; 20(3):e30-3. PubMed ID: 27243142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of women with cervicitis.
    Marrazzo JM; Martin DH
    Clin Infect Dis; 2007 Apr; 44 Suppl 3():S102-10. PubMed ID: 17342663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.
    Nuovo J; Melnikow J; Paliescheskey M; King J; Mowers R
    J Am Board Fam Pract; 1995; 8(1):7-16. PubMed ID: 7701965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men.
    Brunham RC; Paavonen J; Stevens CE; Kiviat N; Kuo CC; Critchlow CW; Holmes KK
    N Engl J Med; 1984 Jul; 311(1):1-6. PubMed ID: 6427611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervicitis aetiology and case definition: a study in Australian women attending sexually transmitted infection clinics.
    Lusk MJ; Garden FL; Rawlinson WD; Naing ZW; Cumming RG; Konecny P
    Sex Transm Infect; 2016 May; 92(3):175-81. PubMed ID: 26586777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cervicitis among women with bacterial vaginosis.
    Marrazzo JM; Wiesenfeld HC; Murray PJ; Busse B; Meyn L; Krohn M; Hillier SL
    J Infect Dis; 2006 Mar; 193(5):617-24. PubMed ID: 16453256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucopurulent cervicitis: no longer ignored, but still misunderstood.
    Marrazzo JM
    Infect Dis Clin North Am; 2005 Jun; 19(2):333-49, viii. PubMed ID: 15963875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervicitis: a review.
    Lusk MJ; Konecny P
    Curr Opin Infect Dis; 2008 Feb; 21(1):49-55. PubMed ID: 18192786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia trachomatis cervicitis in gynecologic outpatients.
    Ripa KT; Svensson L; Mårdh PA; Weström L
    Obstet Gynecol; 1978 Dec; 52(6):698-702. PubMed ID: 104212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervicitis: limited clinical utility for the detection of Mycoplasma genitalium in a cross-sectional study of women attending a New Zealand sexual health clinic.
    Oliphant J; Azariah S
    Sex Health; 2013 Jul; 10(3):263-7. PubMed ID: 23702105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: response of chlamydia-positive and chlamydia-negative forms.
    Chandeying V; Sutthijumroon S; Tungphaisal S
    J Med Assoc Thai; 1989 Jun; 72(6):331-7. PubMed ID: 2778422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Problems of diagnosis and treatment of cervicitis].
    Borisov I; Shopova E; Maĭnkhard K
    Akush Ginekol (Sofiia); 1999; 38(1):60-3. PubMed ID: 11965726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study of clarithromycin versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis.
    Stein GE; Mummaw NL; Havlichek DH
    Pharmacotherapy; 1995; 15(6):727-31. PubMed ID: 8602379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The overall agreement of proposed definitions of mucopurulent cervicitis in women at high risk of Chlamydia infection.
    Falk L
    Acta Derm Venereol; 2010 Sep; 90(5):506-11. PubMed ID: 20814628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydial cervicitis: testing the practice guidelines for presumptive diagnosis.
    Sellors J; Howard M; Pickard L; Jang D; Mahony J; Chernesky M
    CMAJ; 1998 Jan; 158(1):41-6. PubMed ID: 9475908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underrecognition of cervical Neisseria gonorrhoeae and Chlamydia trachomatis infections in pregnant patients in the ED.
    Krivochenitser R; Jones JS; Whalen D; Gardiner C
    Am J Emerg Med; 2013 Apr; 31(4):661-3. PubMed ID: 23391639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urethritis/cervicitis pathogen prevalence and associated risk factors among asymptomatic HIV-infected patients in South Africa.
    Lewis DA; Chirwa TF; Msimang VM; Radebe FM; Kamb ML; Firnhaber CS
    Sex Transm Dis; 2012 Jul; 39(7):531-6. PubMed ID: 22706215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucopurulent cervicitis at a clinic for sexually transmitted diseases].
    Pérez Bernal AM; Hernández Aguado I; Sánchez-Pedreño Guillén P; Feliu Pérez MM; Camacho Martínez F
    Med Cutan Ibero Lat Am; 1987; 15(6):517-22. PubMed ID: 3123821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease.
    Batteiger BE; Jones RB; White A
    Am J Med; 1989 Dec; 87(6C):75S-77S. PubMed ID: 2603894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of wet mount to predict Chlamydia trachomatis and Neisseria gonorrhea cervicitis in primary care.
    Majeroni BA; Schank JN; Horwitz M; Valenti J
    Fam Med; 1996 Sep; 28(8):580-3. PubMed ID: 8884256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.